Stay updated on Dupilumab in Bullous Pemphigoid Adults Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page.

Latest updates to the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page
- ChecktodayChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2, while the page continues to display a 403 error.SummaryDifference0.2%

- Check7 days agoChange DetectedThe site revision label changes from v3.7.0 to v3.7.1. The study page is displaying a 403 Forbidden error rather than trial details.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check28 days agoChange DetectedA 403 Forbidden page is now shown, with a basic header including Home and Revision: v3.7.0; at the same time, a large set of study documents and content (e.g., SAP, IPD sharing, ICF, PDFs, and location data) was removed from the study record.SummaryDifference21%

- Check49 days agoChange DetectedAn NIH grant/contract reference for 2019 was added under Other Study IDs, and the page revision was updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page displays a new revision stamp of v3.6.5, replacing the previous v3.6.4. This indicates a small maintenance update to the page rather than a change to study details or user actions.SummaryDifference0.0%

- Check85 days agoChange DetectedRevision: v3.6.4 is now displayed, replacing the previous Revision: v3.6.3. This appears to be a small metadata update to the page version rather than a change to the study content.SummaryDifference0.0%

Stay in the know with updates to Dupilumab in Bullous Pemphigoid Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page.